Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Platelet-Rich Fibrin in the Prevention of Osteoradionecrosis and Medication-related Osteonecrosis of the Jaw Following Tooth Extractions: A Prospective, Triple-Blind, Randomised Feasibility Trial

NCT07585123 is registered in ClinicalTrials.gov with Swansea Bay University Health Board as lead sponsor.

NCT NCT07585123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07585123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Platelet-Rich Fibrin in the Prevention of Osteoradionecrosis and Medication-related Osteonecrosis of the Jaw Following Tooth Extractions: A Prospective, Triple-Blind, Randomised Feasibility Trial
Lead sponsor
Swansea Bay University Health Board
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 2, 2026
Completion date
July 31, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

medicine related osteonecrosis of the jaw, osteoradionecrosis of the jaw